PacBio’s revenues from the Americas were $33.9 million, up 182% year over year. The uptick was driven by continued growth in instruments and consumables from both new and existing customers.

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...

Gene sequencing specialist PacBio has reached an agreement to buy Apton Biosystems, boosting its position in short-read sequencing technology that has traditionally been dominated by rival Illumina.

PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO). Published first on TheFly ...

This news is based on a press release statement from PacBio. The company's products are intended for research purposes only and are not approved for diagnostic procedures. PacBio has advised that ...

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest ...

The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...

MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and ...

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith ...

PacBio’s earnings surpassed the Zacks Consensus ... PACB is experiencing longer-than-expected sales cycles for Revio instruments due to funding uncertainties, procurement delays in Asia-Pacific ...